- 全部删除
您的购物车当前为空
CAY10721 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (39% SIRT3 inhibition at 200 μM). Upregulation of SIRT3 transcription is associated with oral squamous cell carcinoma (OSCC) and breast cancer with lymph node involvement, while SIRT3 down-regulation inhibits the growth of OSCC cells and sensitizes them to radiation and chemotherapy.

CAY10721 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (39% SIRT3 inhibition at 200 μM). Upregulation of SIRT3 transcription is associated with oral squamous cell carcinoma (OSCC) and breast cancer with lymph node involvement, while SIRT3 down-regulation inhibits the growth of OSCC cells and sensitizes them to radiation and chemotherapy.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 812 | 35日内发货 | |
| 5 mg | ¥ 3,520 | 35日内发货 | |
| 10 mg | ¥ 6,160 | 35日内发货 | |
| 25 mg | ¥ 13,500 | 35日内发货 |
| 产品描述 | CAY10721 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (39% SIRT3 inhibition at 200 μM). Upregulation of SIRT3 transcription is associated with oral squamous cell carcinoma (OSCC) and breast cancer with lymph node involvement, while SIRT3 down-regulation inhibits the growth of OSCC cells and sensitizes them to radiation and chemotherapy. |
| 分子量 | 351.38 |
| 分子式 | C18H13N3O3S |
| CAS No. | 848688-62-0 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: 30 mg/mL (85.38 mM), Sonication is recommended. DMF: 30 mg/mL (85.38 mM), Sonication is recommended. DMSO:PBS(pH 7.2) (1:4): 0.2 mg/mL (0.57 mM), Sonication is recommended. |
评论内容